Leadless Pacemaker Function Timeline
A leadless pacemaker begins working immediately upon implantation and provides effective pacing from the moment it is deployed and activated in the cardiac chamber.
Immediate Function (At Implantation)
The device starts pacing as soon as it is properly positioned and fixated. Based on recent clinical data, electrical parameters at the time of implant demonstrate immediate capture:
- Ventricular leadless pacemakers: Capture threshold of 0.8V (0.5-1.3V range), R-wave amplitude of 9.0 mV, and impedance of 705Ω at deployment 1
- Atrial leadless pacemakers: Capture threshold of 2.4V, sensed amplitude of 1.8 mV at implant 2
The device is tested during the procedure to confirm appropriate sensing and pacing before the delivery catheter is released, ensuring it works properly before you leave the catheterization lab.
Electrical Performance Evolution
While the device functions immediately, electrical parameters actually improve over the first month as the tissue-device interface matures:
First Month Changes:
- Atrial devices: Thresholds improve from 2.4V to 0.8V, and sensed amplitudes increase from 1.8 mV to 3.4 mV 2
- Ventricular devices: Thresholds improve from 0.8V to 0.6V, and sensed amplitudes increase from 8.8 mV to 11.7 mV 2
These improvements reflect lead maturation, not delayed function - the device is working from implant, but becomes more efficient as inflammation resolves and the fixation helix integrates with myocardial tissue.
Stability Period:
From 1-6 months post-implant, electrical measurements remain relatively stable, indicating the device has reached its chronic performance state 2.
Monitoring Requirements
Based on guideline recommendations for all pacemaker types (leadless-specific monitoring guidelines are not yet established):
- Pacemaker-dependent patients: ECG monitoring recommended for 12-24 hours after implantation to detect early complications like loss of capture or lead dislodgement 3, 4
- Non-pacemaker-dependent patients: Monitoring for 12-24 hours may be reasonable for early complication detection 4
Clinical Implications
There is no "waiting period" for the device to start working. If a patient requires pacing, the leadless pacemaker provides it immediately. The device programmer confirms appropriate function before the procedure is completed, with typical implant success rates of 96-98.8% 1, 5.
The common concern about "time to work" likely stems from confusion with traditional pacemaker lead maturation, where capture thresholds can rise in the first weeks. With modern steroid-eluting leads (both traditional and leadless), this threshold rise has been largely eliminated, and leadless devices show threshold improvement rather than deterioration 2, 6.